logo_web
  • Clinical Trials
    • Management of medication
    • Management of reimbursement of expenses to patients
    • Supply of medical devices
    • Destruction
    • Calibration of medical devices
    • Import and labeling of medication
    • Masking. Placebos manufacturing
  • Blog
  • Quality
    • Certifications
    • RSE
  • Clients
  • Patient Reimbursement Forms
    • Validation / Expense Reimbursement Sheet
✕
  • Clinical Trials
    • Management of medication
    • Management of reimbursement of expenses to patients
    • Supply of medical devices
    • Destruction
    • Calibration of medical devices
    • Import and labeling of medication
    • Masking. Placebos manufacturing
  • Blog
  • Quality
    • Certifications
    • RSE
  • Clients
  • Patient Reimbursement Forms
    • Validation / Expense Reimbursement Sheet
11 March, 2026

International cooperation in the pharmaceutical industry: key to innovation and global access

Partnerships between companies and regulatory authorities are becoming an essential strategy for tackling global challenges. Partnerships between companies and regulatory authorities are becoming an essential strategy […]
Like?
Leer más
6 March, 2026

Ayuso announces a 34% increase in investment in scientific research, reaching €752 million

The Community of Madrid aims to strengthen research excellence, attract talent, and consolidate the region as a national and international benchmark in this field. consalud.es The […]
Like?
Leer más
5 March, 2026

The pharmaceutical industry almost triples its investment in Spain

eleconomista.es Twenty years ago, few could have predicted the trajectory that drug research and development would follow in Spain. While the country grappled with the real […]
Like?
Leer más
4 March, 2026

35,000 new patients treated, 18,000 jobs created, and three million sick days avoided: the benefits of meeting EU targets for attracting clinical trials

These are the five-year figures estimated by a new study on the economic impact of industry-sponsored clinical research in the EU, published in Frontiers in Economics […]
Like?
Leer más
9 February, 2026

Artificial intelligence enables more accurate stratification of breast cancer risk

An artificial intelligence model trained solely on mammography images demonstrates greater accuracy than breast density in estimating five-year breast cancer risk, paving the way for more […]
Like?
Leer más
5 February, 2026

From potential to results: how pharmaceutical companies measure the impact of AI on their forecasts

elglobalfarma.com The global pharmaceutical industry is undergoing a quiet but profound transformation in the way it anticipates the future. A new report on forecasting and artificial […]
Like?
Leer más
3 February, 2026

The ‘Guide to Excellence for Conducting Clinical Trials in Hospital Pharmacy’, recognized with the Diagnosis Award

The project, promoted by the Spanish Society of Hospital Pharmacy, the General Council of Pharmacists, and Farmaindustria, has won the award for Best Pharmaceutical Initiative at […]
Like?
Leer más
29 January, 2026

Artificial intelligence accelerates drug development, but has yet to discover the miracle molecule

Although AI has not yet achieved major medical advances on its own, the industry already uses it to save time and costs and speed up trials. […]
Like?
Leer más
27 January, 2026

GEPAC and Farmaindustria sign an agreement to promote research, access to innovation, and the measurement of health outcomes in oncology

Both entities are committed to promoting activities that raise awareness of patient associations in Spain, with a special focus on organizations linked to oncology. Begoña Barragán, […]
Like?
Leer más
27 January, 2026

The pharmaceutical industry values the ten commandments of good practice in the use of AI in drug development, drawn up by the EMA and the FDA.

Both regulatory agencies recognize the potential of this technology to transform biomedical innovation and hope to help lay the groundwork for joint work among stakeholders in […]
Like?
Leer más
20 January, 2026

Spain once again leads clinical trials in Europe, but faces the challenge of competing in the global biomedical race

Our country authorized 962 studies last year, a hundred more than in 2023. Four out of every 10 research projects were dedicated to finding new cancer […]
Like?
Leer más
14 January, 2026

Spain leads clinical research in the EU: 962 trials authorized and record administrative agility

The Spanish Registry of Clinical Studies points out that the country’s excellent hospital network and regulatory efficiency make it a strategic destination for the development of […]
Like?
Leer más
1234567891011121314151617181920212223242526
Next page

CENTRAL

Pol. PIBO. Avda. de Gines, 14
+34 955 776 767 /+34 692 454 913
41110 Bollullos de la Mitación (Sevilla)

DELEGACIÓN MADRID

+34 674 575 115
28010 Madrid

Enlaces de interés

  • Legal warning
  • Privacy policy
  • Cookies policy
  • Contact

© 2026 Distefar del Sur SL. Todos los derechos reservados. agencianodo.com

    [recaptcha]

    In accordance with the provisions of Regulation (EU) 2016/679 and Organic Law 3/2018 regarding Data Protection, we inform you that the data you provide in this form will be incorporated into a file owned by DISTEFAR DEL SUR, SL domiciled in the C / Umbrete 58, (Pol. Ind. Pibo), 41110 of Bollullos de la Mitación (Seville), in order to manage your request.

    In this regard, and if you wish to exercise your rights of access, rectification, cancellation, opposition, portability and limitation, please send a written communication to DISTEFAR DEL SUR, SL, to the address indicated above or to info@distefar.com, attaching copy of your National Identity Document or equivalent identification document.

    Basic information about Data Protection

     Epigraph

    Basic information Data Protection

    Responsable

    DISTEFAR DEL SUR, S.L.

    Purpose

    Process your inquiry / request
    Detailed information on Data Protection

    Legitimation

    Consent
    Detailed information on Data Protection

    Recipients

    It is not expected to carry out data communications to third parties, except legal obligation
    Transfers of data to third countries outside the European Union will not be carried out
    Detailed information on Data Protection

    Rights

    You have the right of access, rectification, deletion, portability of your data, as well as limitation or opposition to your treatment, as detailed in Detailed information on Data Protection

    Additional Information

    You can consult the additional and detailed information on data protection by clicking here Detailed information on Data Protection

    All the data requested / The fields marked with * in the form are mandatory, if not filled in DISTEFAR DEL SUR, S.L. will not be able to meet your request.

    Distefar del Sur
    Gestión de la medicación Reembolso de gastos a pacientes Suministro de dispositivos médicos Destrucción Calibración de dispositivos médicos Importación y etiquetado Enmascaramiento. Fabricación de placebos
    Blog
    Certificaciones RSE
    Clientes
    Hoja de Validación / Reembolso de Gastos
    Contactar
    +34 955 776 767 info@distefar.com
    ES ES EN EN